Letters
Varenicline’s adverse events
Choice of summary statistics: relative and absolute measures
BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f1092 (Published 26 February 2013) Cite this as: BMJ 2013;346:f1092
This article has a correction. Please see:
- Judith J Prochaska, associate professor1,
- Joan F Hilton, professor2
- 1Department of Psychiatry and Center for Tobacco Control Research and Education, University of California, San Francisco, CA 94143-0984, USA
- 2Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA
- JProchaska{at}ucsf.edu
Our 2012 meta-analysis of cardiovascular related serious adverse events associated with varenicline use has had more than 12 000 online full text viewings.1 In this article we drew attention to an earlier widely publicised meta-analysis,2 which differed from ours in its outcome definition and choice of summary statistic. We restricted outcomes to treatment emergent adverse events in active and placebo arms, whereas the earlier study allowed differential outcome follow-up by arm,2 which extended beyond the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.